Status Epilepticus
📧 Sign up to get email alerts when something new happens for Status Epilepticus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-09-10FDA Approved: LORAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for lorazepam submitted by Teva Pharmaceuticals USA, Inc., under the existing approval of the dr…
-
FDA approval · 2008-03-18FDA Approved: FOSPHENYTOIN SODIUM — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for fosphenytoin sodium (ANDA 078476), establishing a generic option for seiz…
-
FDA approval · 2007-08-06FDA Approved: FOSPHENYTOIN — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original ANDA for fosphenytoin sodium (FOSPHENYTOIN) by Fresenius Kabi USA, LLC.
-
FDA approval · 2007-08-06FDA Approved: FOSPHENYTOIN SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the original ANDA for fosphenytoin sodium, a generic version of the anticonvulsant, manufactured by Hikma Pharmaceuticals USA I…
-
FDA approval · 2006-11-29FDA Approved: LORAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lorazepam by Hikma Pharmaceuticals USA Inc., authorizing modifications under the supplement.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.